As of Q2'26 (2025-12-28), LRCX reported R&D Expenses of $573.3M and SG&A Expenses of $267.7M. This marks a slight decrease in both categories compared to the previous quarter, where R&D Expenses were $576.4M and SG&A Expenses were $279.3M. Over the period from Q3'23 to Q2'26, both R&D and SG&A Expenses have shown a general upward trend, with R&D Expenses increasing from $429.5M to a peak of $580.2M in Q4'25 before a modest decline. SG&A Expenses also rose from $193.5M to a high of $279.3M in Q1'26, followed by a slight pullback. The data indicates consistent investment in both research and administrative functions, with notable growth particularly in the latter half of the period.